-
Exploring a New Frontier
AACR patient advocate forum addresses developments in cancer early detection tests.
by Thomas Celona
-
October 14: The Week in Cancer News
Colonoscopy study results are misreported, and progress is seen in cancer vaccines.
by Kevin McLaughlin
-
Forward Look
A New Breast Cancer SubtypeClinical trial results are changing care for people with metastatic breast cancer that expresses low levels of HER2 protein.
by Kris Conner
-
October 7: The Week in Cancer News
Transportation barriers increase risk of death for people with cancer, and new rules go into effect to give patients full access to medical records.
by Marci A. Landsmann
-
Cancer and Alcohol
Lowering and increasing alcohol consumption is associated with changes in cancer risk.
by Teresa Bergen
-
September 30: The Week in Cancer News
Firefighters face increased cancer risk due to exposure to ‘forever chemicals,’ and cancer-related fatigue can put breast cancer survivors at risk for falls.
by Thomas Celona
-
Grapefruit: The Healthy Fruit With a Potentially Dangerous Downside
The health benefits of grapefruit are well known, but cancer patients should be aware of potentially harmful interactions it can have with common medicines.
by Anne Danahy
-
September 23: The Week in Cancer News
AACR Cancer Progress Report 2022 shows continued decline in cancer death rates, and genetic tests create opportunities but also confusion for breast cancer patients.
by Eric Fitzsimmons
-
Thinking Outside the Clinic
Researchers highlight need for outreach and educational programs to address survivorship disparities.
by Thomas Celona
-
Cultural Competence in the Community
Researchers describe their efforts to understand and improve cancer screening and treatment among underserved populations.
by Kevin McLaughlin
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles